Pulmatrix Inc (PULM)

6.12 +0.01 (+0.16%) USD  |  NASDAQ  |  Nov 22, 16:00
6.145 +0.02 (+0.41%) After-Hours: 20:00
More

Pulmatrix Debt to Equity Ratio: 0.00 for Sept. 30, 2024

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2015. Upgrade now.
Date Value
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
Date Value
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.3353
December 31, 2017 0.3177
September 30, 2017 0.3049
June 30, 2017 0.2881
March 31, 2017 0.3259
December 31, 2016 0.6624
September 30, 2016 0.3666
June 30, 2016 0.3365
March 31, 2016 0.2397
December 31, 2015 0.2061
September 30, 2015 0.1873
June 30, 2015 0.1706

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019

Debt to Equity Ratio Benchmarks

Entero Therapeutics Inc --
Johnson & Johnson 0.5096
Savara Inc --
NovaBay Pharmaceuticals Inc 0.0476
Palatin Technologies Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 11.51M
Total Liabilities (Quarterly) 0.59M
Shareholders Equity (Quarterly) 10.92M
Current Ratio 19.40